Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide.

  • Philp D
  • Kleinman H
  • 22


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Studies in various animal models of disease and repair with thymosin beta(4) (Tbeta(4)), the major actin-sequestering molecule in mammalian cells, have provided the scientific foundation for the ongoing dermal, corneal, and cardiac wound repair multicenter clinical trials. Tbeta(4) has of multiple biological activities, which include down-regulation of inflammatory chemokines and cytokines, and promotion of cell migration, blood vessel formation, cell survival, and stem cell maturation. All of these activities contribute to the multiple wound healing properties that have been observed in animal studies. This paper reviews and discusses the topical and systemic uses of Tbeta(4) in various animal models that demonstrate its potential for clinical use.

Author-supplied keywords

  • Actins
  • Actins: metabolism
  • Administration, Topical
  • Animals
  • Cell Differentiation
  • Cell Movement
  • Chemokines
  • Cornea
  • Cornea: metabolism
  • Cytokines
  • Down-Regulation
  • Hormones
  • Immunologic Factors
  • Inflammation
  • Inflammation: drug therapy
  • Peptides
  • Rats
  • Regeneration
  • Thymosin
  • Thymosin: metabolism
  • Thymosin: physiology
  • Thymosin: therapeutic use
  • Wound Healing
  • Wound Healing: physiology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Deborah Philp

  • Hynda K Kleinman

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free